Non-small cell lung cancer (NSCLC) is a type of cancer that begins in the tissues of the lungs, the two spongy organs in your chest that help your body absorb oxygen. Lung cancer is the third most ...

“This is quite exciting,” said Dr. Shirish M. Gadgeel, a medical oncologist at the Henry Ford Cancer Institute in Detroit.

SIADH (syndrome of inappropriate antidiuretic hormone secretion) leads to hyponatremia water retention in hospitalized or ...

In more than a dozen years spent reviewing shows at the Edinburgh Festival Fringe, the world's largest arts festival, I struggle to remember laughing quite so much as I did at Identities, a 1-hour ...

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...

Panelists discuss how HER2-directed therapies in non–small cell lung cancer (NSCLC) are evolving, with experts examining the distinction between HER2 mutation and expression, evaluating the efficacy ...

Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell ...

Hatim Husain, MD, discusses how acquired resistance to kinase inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC) poses a significant challenge in long-term treatment efficacy, necessitating ...

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds.

A new study found that women ages 35 to 54 are experiencing higher rates of new lung cancer cases than men in that age group. Experts aren't quite sure why this is the case, as cigarette smoking—the ...

A 90-year-old man visited our hospital with a chief problem of haemoptysis lasting for a month. He had a medical history of bladder cancer, including transurethral resection, 10 years previously.

The single mom of two young set a modest target of just $5,000 to cover her funeral costs—but this was smashed as her tragic ...